SG149080A1 - Composition comprising a nsaid and paracetamol - Google Patents

Composition comprising a nsaid and paracetamol

Info

Publication number
SG149080A1
SG149080A1 SG200900013-4A SG2009000134A SG149080A1 SG 149080 A1 SG149080 A1 SG 149080A1 SG 2009000134 A SG2009000134 A SG 2009000134A SG 149080 A1 SG149080 A1 SG 149080A1
Authority
SG
Singapore
Prior art keywords
paracetamol
nsaid
composition
forming
melt
Prior art date
Application number
SG200900013-4A
Other languages
English (en)
Inventor
Robert Sherry
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35335274&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG149080(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Publication of SG149080A1 publication Critical patent/SG149080A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SG200900013-4A 2005-09-22 2006-09-07 Composition comprising a nsaid and paracetamol SG149080A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0519350.3A GB0519350D0 (en) 2005-09-22 2005-09-22 Therapeutic agents

Publications (1)

Publication Number Publication Date
SG149080A1 true SG149080A1 (en) 2009-01-29

Family

ID=35335274

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200900013-4A SG149080A1 (en) 2005-09-22 2006-09-07 Composition comprising a nsaid and paracetamol

Country Status (13)

Country Link
US (1) US20090142392A1 (OSRAM)
EP (2) EP1926477B1 (OSRAM)
JP (1) JP2009508916A (OSRAM)
KR (2) KR20130141728A (OSRAM)
CN (1) CN101267807B (OSRAM)
AU (1) AU2006293798B2 (OSRAM)
CA (1) CA2623281A1 (OSRAM)
GB (1) GB0519350D0 (OSRAM)
PL (2) PL1926477T3 (OSRAM)
RU (1) RU2438656C2 (OSRAM)
SG (1) SG149080A1 (OSRAM)
WO (1) WO2007034135A1 (OSRAM)
ZA (1) ZA200802436B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007000117A (es) 2004-07-07 2007-06-15 Aft Pharmaceuticals Ltd Una composicion de combinacion.
GB2447898B (en) * 2007-03-24 2011-08-17 Reckitt Benckiser Healthcare A tablet having improved stability with at least two actives
WO2009087410A2 (en) * 2008-01-11 2009-07-16 Cipla Limited Solid pharmaceutical dosage form
WO2009128543A1 (ja) * 2008-04-17 2009-10-22 ニプロ株式会社 シリカを含む錠剤の製造方法、錠剤及び錠剤用複合粒子
US20110166234A1 (en) * 2008-10-14 2011-07-07 Atkinson Hartley Campbell Medicinal product and treatment
ES2365961B1 (es) * 2010-03-30 2013-01-24 Farmasierra Manufacturing S.L. Formulación farmacéutica a base de ibuprofeno y codeína de estabilidad mejorada.
CN105816434B (zh) * 2016-04-19 2019-09-17 山东新华制药股份有限公司 布洛芬颗粒及其制备方法
EP3700509B1 (en) 2017-11-29 2023-11-22 Ilko Ilaç Sanayi Ve Ticaret Anonim Sirketi Color stable fixed dose tablet combination of ibuprofen and paracetamol
US20190350883A1 (en) * 2018-05-20 2019-11-21 Luan Chau Pharmaceutical Composition of Acetaminophen/Ibuprofen
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
US11779541B2 (en) 2019-03-26 2023-10-10 Johnson & Johnson Consumer Inc. Immediate release dosage form
US11918693B2 (en) * 2019-06-27 2024-03-05 Haleon Us Holdings Llc Ibuprofen and acetaminophen tablet
CN110372713B (zh) * 2019-08-15 2022-05-17 广州市汉普医药有限公司 一种普拉洛芬的精制纯化方法
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271811A (en) * 1988-01-29 1993-12-21 Hoechst Celanese Corporation Process for purifying 2-(4-isobutylphenyl)-propionic acid by vacuum distillation
DE3802619C1 (OSRAM) 1988-01-29 1989-09-07 Hoechst Ag, 6230 Frankfurt, De
DE3833448A1 (de) 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
DE4446468A1 (de) * 1994-12-23 1996-06-27 Basf Ag Verfahren zur Herstellung von umhüllten Tabletten
JP3982889B2 (ja) * 1997-11-28 2007-09-26 あすか製薬株式会社 イブプロフェン含有医薬製剤
US6787157B1 (en) * 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
RU2192248C2 (ru) * 1998-07-13 2002-11-10 Товарищество с ограниченной ответственностью фирма "Эйкос" Препарат "антигриппин"
JP4040878B2 (ja) 1999-12-09 2008-01-30 レキット ベンキーザー ヘルスケア （ユーケイ） リミテッド 治療薬
GB0113841D0 (en) 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
RU2237470C1 (ru) * 2003-01-27 2004-10-10 Купсин Евгений Вениаминович Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты)
US20040265378A1 (en) * 2003-06-25 2004-12-30 Yingxu Peng Method and compositions for producing granules containing high concentrations of biologically active substances
WO2006016125A1 (en) * 2004-08-12 2006-02-16 Reckitt Benckiser Healthcare (Uk) Limited Granules comprising a nsaid and a sugar alcohol made by melt extrusion
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents

Also Published As

Publication number Publication date
ZA200802436B (en) 2009-07-29
RU2438656C2 (ru) 2012-01-10
EP2851068A3 (en) 2015-05-27
EP1926477A1 (en) 2008-06-04
KR20130141728A (ko) 2013-12-26
KR101434906B1 (ko) 2014-08-27
CA2623281A1 (en) 2007-03-29
AU2006293798B2 (en) 2012-08-16
PL2851068T3 (pl) 2020-04-30
EP2851068B1 (en) 2019-10-23
CN101267807B (zh) 2013-04-10
EP2851068A2 (en) 2015-03-25
AU2006293798A1 (en) 2007-03-29
CN101267807A (zh) 2008-09-17
JP2009508916A (ja) 2009-03-05
KR20080047437A (ko) 2008-05-28
PL1926477T3 (pl) 2017-09-29
GB0519350D0 (en) 2005-11-02
EP1926477B1 (en) 2017-04-19
US20090142392A1 (en) 2009-06-04
WO2007034135A1 (en) 2007-03-29
RU2008115507A (ru) 2009-10-27

Similar Documents

Publication Publication Date Title
SG149080A1 (en) Composition comprising a nsaid and paracetamol
GEP20125378B (en) Pharmaceutical compositions
TNSN07415A1 (en) Extrusion process for making compositions with poorly compressible therapeutic compounds
MX2007001597A (es) Granulos que comprenden paracetamol, un farmaco antiinflamatorio no esteroidal y un alcohol de azucar hecho por extrusion por fusion.
WO2008037716A3 (en) Pharmaceutical compositions comprising nilotinib or its salt
WO2010003078A3 (en) Melt granulation process
IL185325A0 (en) Process for the production of calcium compositions in a continuous fluid bed
MY173730A (en) Orally-disintegrating solid preparation
EP2214231A4 (en) POSITIVE ELECTRODE ACTIVE MATERIAL, MANUFACTURING METHOD AND ELECTROCHEMICAL EQUIPMENT
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
WO2008014175A3 (en) Granular pharmaceutical compositions
DK1598333T3 (da) Fremgangsmåde til fremstilling af (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutan og syreadditionssalte heraf samt anvendelse til syntese af ivabradin og syreadditionssalte heraf med farmaceutisk acceptable syrer
HRP20090194T1 (hr) Suha granulirana kompozicija koja sadrži emtricitabin i tenofovir df
AR055561A1 (es) Comprimidos con dispersion mejorada de la sustancia farmacologica
IL197089A0 (en) Pharmaceutical formulations comprising clopidogrel
BR0209115A (pt) Composição granular e processo para sua produção
PL1888514T3 (pl) Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych
TW200716199A (en) Lozenge production process
BR0209834A (pt) Produto granulado fundido, processo para a preparação do mesmo, composição, e, forma de dosagem unitária farmacêutica moldada sólida
MXPA02010828A (es) Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
TW200718434A (en) Method for producing granular oral composition with oligosaccharide solution
BRPI0518786A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
BRPI0518790A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
ZA200506992B (en) Fibrate tablet and method for the production thereof
AR034435A1 (es) Agentes terapeuticos.